The National Institute on Drug Abuse (NIDA) seeks capability statements from qualified Small Businesses (NAICS 541380, small business size standard is 6 million) for the quantitative analysis of cannabinoids, cocaine and metabolites, opiates, l-alpha-acetylmethadol, phencyclidine, LSD and other drugs of abuse in biological fluids (blood, saliva, plasma, urine) and tissues by means of gas chromatography/mass spectrometry (GC/MS). The analyses must be specific and sensitive as required for pharmacokinetic studies (generally in the low ng/ml range). The offeror must possess the necessary laboratory space, instrumentation, and experience in assays of cannabinoids and other drugs of abuse to carry out these tasks. Information sent should be relevant and specific in the technical area under consideration, on each of the following qualifications: (1) Experience: An outline of previous projects, specific to quantitative analysis performed and any in-house research and development effort; (2) Personnel: Name, professional qualifications and specific experience of scientists and technical personnel who may be assigned as principal investigator and/or project director; (3) Facilities: Provide availability and description special facilities and equipment required to perform quantitative analysis and any other specific and relevant information about this particular area of procurement that would improve our consideration and evaluation of the information presented is desirable. Interested organizations must demonstrate and document, in any capability statements submitted, extensive experience with and the ability to perform the above tasks. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but not be limited to, contracts both Government and commercial the organization performed, references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability, e.g., awards, commendations, etc. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. This is not a request for proposals. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent or the Government's use of the information. Any proprietary information should be so marked. Interested organizations presenting a capability statement in response to this sources sought announcement must identify their size status. Offerors must send written capability statements by April 28, 2003 to the NIDA Contracting Officer at: If using U.S. Postal Service - National Institute on Drug Abuse, NIH, Contracts Management Branch, OPRM, 6001 Executive Boulevard, Room 3105, MSC 9543, Bethesda, Maryland 20892-9543 OR, if hand-delivered or delivery service - National Institute on Drug Abuse, NIH, Contracts Management Branch, OPRM, 6001 Executive Boulevard, Room 3105, Rockville, Maryland 20852 Original Point of Contact Dawn Rabunsky, Contract Specialist, Phone (301)443-6677, Fax (301)443-7595, Email [email protected]

Bid Protests Not Available